DHR
66
2
SHW
43
-10
WFC
74
5
AVY
47
-7
TXN
50
2
EFX
54
2
LLY
71
3
ED
37
-6
PH
62
2
TMO
60
4
BF.B
48
-2
IP
28
-3
STZ
42
-2
PBI
68
2
ROK
47
4
CRM
70
18
EOG
33
-3
A
43
-5
HPE
75
7
HIG
68
5
DHR
66
2
SHW
43
-10
WFC
74
5
AVY
47
-7
TXN
50
2
EFX
54
2
LLY
71
3
ED
37
-6
PH
62
2
TMO
60
4
BF.B
48
-2
IP
28
-3
STZ
42
-2
PBI
68
2
ROK
47
4
CRM
70
18
EOG
33
-3
A
43
-5
HPE
75
7
HIG
68
5
Financhill
Back

Transat A.T., Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell
40

TRZ.TO
Transat A.T., Inc.

Last Price:
$2.63
Seasonality Move:
5.11%
Sell
23

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$33.50
Seasonality Move:
-0.96%
Sell
40
Transat A.T., Inc. (TRZ.TO) is a Sell

Is Transat A.T., Inc. a Buy, Sell or Hold?

  • The current Transat A.T., Inc. [TRZ.TO] share price is $2.63. The Score for TRZ.TO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • TRZ.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TRZ.TO Stock Price Chart

What is Transat A.T., Inc.'s stock price today?

  • The Transat A.T., Inc. share price today is $2.63
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRZ.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.

TRZ.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.48 Buy
Relative Strength Index (14 RSI): 58.93 Buy
Chaikin Money Flow: 84974 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.17 - 2.63) Buy
Bollinger Bands (100): (2.26 - 2.78) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.24 Buy
Relative Strength Index (14 RSI): 45.54 Sell
Chaikin Money Flow: 579058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.19 - 34.19) Buy

TRZ.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.6 Buy
20-day SMA: 2.47 Buy
50-day SMA: 2.33 Buy
200-day SMA: 2.24 Buy
8-day EMA: 1.36 Buy
20-day EMA: 0.67 Buy
50-day EMA: 0.29 Buy
200-day EMA: 0.08 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.82 Sell
20-day SMA: 34.8 Sell
50-day SMA: 33.74 Sell
200-day SMA: 33.57 Sell
8-day EMA: 17.59 Buy
20-day EMA: 8.61 Buy
50-day EMA: 3.75 Buy
200-day EMA: 0.98 Buy

Transat A.T., Inc. Earnings Growth & TRZ.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.71 per share, and an increase next year of $1.23 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Transat A.T., Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):